SCHEMBL2020902

SCHEMBL2020902

COC1=C(O)C=CC(C=CC(=O)c2c(O)cc(O)cc2O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 6/20 0.43
SLC5A2 P31639 6/20 0.43
MAPT P10636 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
KCNA3 P22001 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP19A1 P11511 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CYP3A4 P08684 4/20 0.37
CHRNA7 P36544 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.35
NFKB1 P19838 1/20 0.33
DPP4 P27487 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2023203 0.88 AURKA (0.40) SLC5A1SLC5A2CYP2C9CYP2C19CYP19A1
SCHEMBL2023335 0.84 MEN1 (0.47) MAPTKMT2AMEN1NPSR1CYP2C9
SCHEMBL27084458 0.83 MEN1 (0.41) SLC5A1SLC5A2MAPTKMT2AMEN1
SCHEMBL2024880 0.81 CAPN1 (0.44) MAPTKMT2AMEN1MAOBDPP4
SCHEMBL30932999 0.80 ALDH1A1 (0.33) ATMHSD17B10
SCHEMBL3396798 0.79 MAOB (0.45) MAPTKMT2AMEN1CYP2C9CYP2C19
SCHEMBL22344821 0.79 HCAR2 (0.34) MAPTKMT2AMEN1CYP2C9CYP2C19
SCHEMBL22207958 0.79 ALDH1A1 (0.33) ATM
SCHEMBL22207941 0.79 ALDH1A1 (0.33) ATM
Phloretin SCHEMBL2157151 0.78 SLC5A1 (0.46) SLC5A1SLC5A2MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP claimed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP claimed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US claimed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO claimed
US-9445606-B2 Use of 4-hydroxydihydrochalcones and their salts for enhancing an impression of sweetness SYMRISE AG (DE) 2016-09-20 US disclosed
US-9198451-B2 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2015-12-01 US disclosed
US-8778987-B2 Use of 4-hydroxychalcone derivatives for masking an unpleasant taste SYMRISE AG (DE) 2014-07-15 US disclosed
EP-2340719-B1 Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners SYMRISE AG (DE) 2014-02-19 EP disclosed
EP-2220945-B1 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners SYMRISE AG (DE) 2013-03-27 EP disclosed
EP-2340719-A1 Aroma composition comprising o-coumaric acid to reduce or suppress undesirable taste impressions of sweeteners Symrise AG (DE) 2011-07-06 EP disclosed
US-20110158919-A1 AROMA COMPOSITION COMPRISING O-COUMARIC ACID TO REDUCE OR SUPPRESS UNDESIRABLE TASTE IMPRESSIONS OF SWEETENERS SYMRISE AG (DE) 2011-06-30 US disclosed
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2010-09-16 US disclosed
EP-2220945-A1 Aroma composition to reduce or suppress undesirable bitter and astringent taste impressions of sweeteners Symrise GmbH & Co. KG (DE) 2010-08-25 EP disclosed
US-20100151055-A1 Aroma Composition to Reduce or Suppress Undesirable Bitter and Astringent Taste Impressions of Sweeteners SYMRISE GMBH & CO. KG (DE) 2010-06-17 US disclosed
EP-1998636-B1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO KG (DE) 2010-05-19 EP disclosed
EP-1998636-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS Symrise GmbH & Co. KG (DE) 2008-12-10 EP disclosed
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS SYMRISE GMBH & CO. KG (DE) 2008-10-02 US disclosed
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE SYMRISE GMBH & CO. KG (DE) 2008-09-18 US disclosed
WO-2007107596-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS SYMRISE GMBH & CO. KG (DE) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080227867-A1 USE OF 4-HYDROXYCHALCONE DERIVATIVES FOR MASKING AN UPLEASANT TASTE TAS2R45, TAS2R43, TAS2R30 SLC5A1 1320/4885SLC5A2 1531/4885MAPT 3371/4885
US-20080242740-A1 AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS TAS2R5, TAS2R20, TAS2R40 SLC5A1 1754/4885SLC5A2 1282/4885MAPT 3701/4885
US-20100233102-A1 USE OF 4-HYDROXYDIHYDROCHALCONES AND THEIR SALTS FOR ENHANCING AN IMPRESSION OF SWEETNESS TAS2R4, TAS2R1, TAS2R20 SLC5A1 199/4885SLC5A2 302/4885MAPT 4633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.